Trademark: 90544506
Status Date
Monday, December 18, 2023
Filing Date
Wednesday, February 24, 2021
Published for Opposition
Tuesday, April 26, 2022
41 Providing information, namely, providing online, non-downloadable articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery
5 Medicines for the modification of genes and treatment of diseases, for use in the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; cell and gene therapy preparations and pharmaceutical preparations with protein expression, all for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; drug carriers for medical use, namely, delivery agents in the form of non-viral lipid nanoparticles for delivering drugs to human organs
44 Providing medical information in the fields of genetic medicine and drug delivery
42 Scientific and biotechnology research and analysis in the fields of cell and gene therapy and drug delivery; research and development of medicines and drug delivery platforms for the treatment of diseases; providing scientific research and medical research information in the fields of genetic medicine and drug delivery
SELECTIVE ORGAN TARGETING LIPID NANOPARTICLE
Dec 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 18, 2023
Sou Extension 3 Granted
Dec 18, 2023
Sou Extension 3 Filed
Dec 18, 2023
Sou Teas Extension Received
Jun 20, 2023
Notice Of Approval Of Extension Request E-Mailed
Jun 16, 2023
Sou Extension 2 Granted
Jun 16, 2023
Sou Extension 2 Filed
Jun 16, 2023
Sou Teas Extension Received
Dec 23, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 21, 2022
Sou Extension 1 Granted
Dec 21, 2022
Sou Extension 1 Filed
Dec 21, 2022
Sou Teas Extension Received
Jun 21, 2022
Noa E-Mailed - Sou Required From Applicant
Apr 26, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 26, 2022
Published For Opposition
Apr 6, 2022
Notification Of Notice Of Publication E-Mailed
Mar 23, 2022
Approved For Pub - Principal Register
Mar 23, 2022
Examiner's Amendment Entered
Mar 23, 2022
Notification Of Examiners Amendment E-Mailed
Mar 23, 2022
Examiners Amendment E-Mailed
Mar 23, 2022
Examiners Amendment -Written
Mar 15, 2022
Teas/Email Correspondence Entered
Mar 14, 2022
Correspondence Received In Law Office
Mar 14, 2022
Teas Response To Office Action Received
Sep 20, 2021
Notification Of Non-Final Action E-Mailed
Sep 20, 2021
Non-Final Action E-Mailed
Sep 20, 2021
Non-Final Action Written
Sep 17, 2021
Assigned To Examiner
May 25, 2021
New Application Office Supplied Data Entered
Feb 27, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
